Finance

Beta
Ask
Lists
STTK:NASDAQ
Shattuck Labs Inc
$5.24
+5.86%
(+0.29) 1D
$5.24
0.00% (0.00)
After hours
Closed: Jun 22, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STTK...
Open
$5.00
High
$5.28
Low
$5.00
Mkt. cap
473.55M
Avg. vol.
943.02K
Volume
546.65K
52-wk high
$8.33
52-wk low
$0.71
EPS
-$0.64
Beta
1.08
Shares outstanding
87.56M
No. of employees
40
Open
$5.00
High
$5.28
Low
$5.00
Mkt. cap
473.55M
Avg. vol.
943.02K
Volume
546.65K
52-wk high
$8.33
52-wk low
$0.71
EPS
-$0.64
Beta
1.08
Shares outstanding
87.56M
No. of employees
40
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to STTK in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for STTK in the last 3 months.
Highest
Current $5.24
$18.00 (+243.51%)
Average
$15.80 (+201.53%)
Lowest
$11.00 (+109.92%)
News stories
From sources across the web
About Shattuck Labs Inc
CEO-
Employees40
Founded2016
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websiteshattucklabs.com
Analyst Ratings
Based on 7 analysts giving stock ratings to STTK in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for STTK in the last 3 months.
Highest
Current $5.24
$18.00 (+243.51%)
Average
$15.80 (+201.53%)
Lowest
$11.00 (+109.92%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Yigal Nochomovitz
Citi
Buy
Reiterated
$18.00
+243.5%
06/09/2026
Joseph Stringer
Needham
Buy
Reiterated
$17.00
+224.4%
06/08/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$18.00
+243.5%
06/09/2026
David Nierengarten
Wedbush
Buy
Maintained
$11.00
+109.9%
05/08/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/07/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Initiated
-
-
04/27/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$15.00
+186.3%
04/13/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.13 / -$0.13
+1.52%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
1.00M
-
-
Cost of goods sold
8.68M
7.62M
-23.27M
10.95M
Cost of revenue
8.68M
7.62M
-23.27M
10.95M
Research and development expenses
-
-
32.24M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.35M
4.10M
4.32M
4.60M
Operating expense
4.35M
4.10M
36.56M
4.60M
Total operating expenses
13.03M
11.72M
13.29M
15.54M
Operating income
-13.03M
-10.72M
-13.29M
-15.54M
Other non operating income
574.00K
660.00K
-1.92M
-1.00K
EBT including unusual items
-12.46M
-10.06M
-12.59M
-14.77M
EBT excluding unusual items
-12.46M
-10.06M
-12.51M
-14.77M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.46M
-10.06M
-12.59M
-14.77M
Net profit margin
-
-1,005.60%
-
-
Earnings per share
-0.24
-0.14
-0.12
-0.13
Interest and investment income
-
-
2.70M
779.00K
Interest expense
-
-
-
-
Net interest expenses
-
-
2.70M
779.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.10M
-9.80M
-12.38M
-14.65M
Gain or loss from assets sale
-
47.00K
-47.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer